Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-23T13:28:26.566Z Has data issue: false hasContentIssue false

Therapeutic drug monitoring

Published online by Cambridge University Press:  18 September 2015

J.B.G.M. Noten*
Affiliation:
Ziekenhuisapotheker, Farmaceutisch Laboratorium, Stichting, ZALV, Venray
W.M.A. Verhoeven
Affiliation:
Zenuwarts/A-opleider, respectievelijk psychiater, Vincent van Gogh Instituut voor Psychiatrie, Venray
S. Tuinier
Affiliation:
Zenuwarts/A-opleider, respectievelijk psychiater, Vincent van Gogh Instituut voor Psychiatrie, Venray
D. Touw
Affiliation:
Ziekenhuisapotheker, Apotheek Academisch Ziekenhuis, Vrije Universiteit, Amsterdam
*
ziekenhuisapotheker, Z.A.L.V. Farmaceutisch Laboratorium, Hoenderstraat 95b, 5801 CJ Venray

Summary

The cytochrome P450 iso-enzyme system plays a key role in the biotransformation of many drugs, including psychotropics. Its activity is determined by both genetic and environmental factors. The most important iso-enzymes for psychiatry in general are P450 IID6, 3A4 and 1A2. Knowledge about the involvement of these enzymes and biotransformation processes is mandatory because of the individual variability in their metabolic capacity. Regular measurement of plasmaconcentrations of (psycho)pharmacological compounds is therefore essential. In addition, the potential value of pheno- and/or genotyping has to be investigated.

Type
Research Article
Copyright
Copyright © Scandinavian College of Neuropsychopharmacology 1999

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Literatuur

1.Touw, DJ, Verhoeven, WMA, Noten, JBG. Het cytochroom P450 enzymsysteem: wat is de relevantie voor de praktijk? Deel 1: De iso-enzymen. Acta neuropsychiat 1998; 10: 3442.CrossRefGoogle Scholar
2.Touw, DJ, Verhoeven, WMA, Noten, JBG. Het cytochroom P450 enzymsysteem: wat is de relevantie voor de praktijk? Deel 2: Interacties. Acta neuropsychiat, 1998; 10: 5862.CrossRefGoogle Scholar